The QT interval, its origin and importance of the knowledge of formulas for its measurement in different clinical circumstances

Elibet Chávez González

2014, Number 1

<< Back Next >>

CorSalud 2014; 6 (1)

The QT interval, its origin and importance of the knowledge of formulas for its measurement in different clinical circumstances

Chávez GE

Full text

How to cite this article

Language: Spanish
References: 28
Page: 79-85
PDF size: 303.65 Kb.

ABSTRACT

The long QT syndrome is an arrhythmogenic channelopathy characterized by severe alterations in ventricular repolari-zation, electrocardiographically translated as a QT interval prolongation. The involvement of various ion channels in the genesis of cardiac action potential causes that altera-tions in their structure and function lead to the so-called syndrome and to the presence of malignant ventricular arrhythmias. In 1920, Bazett adapted the formula of the cardiac electrical systole duration to the QT interval of the electrocardiogram, and proposed normal values of QT for a given heart rate. After Bazett’s description, several formulas were described in different clinical situations to calculate the corrected QT interval. The knowledge about how to measure the QT interval and about its correction as a tool for the diagnosis of arrhythmogenic conditions and prevention of primary or secondary malignant ventricular arrhythmias is of vital importance for its clinical use.

REFERENCES

Medeiros-Domingo A, Iturralde-Torres P, Acker-man MJ. Clínica y genética en el síndrome de QT largo. Rev Esp Card. 2007;60(7):739-52.
Márquez MF. El síndrome de QT largo: una breve revisión del diagnóstico electrocardiográfico inclu-yendo la prueba de Viskin. Arch Cardiol Mex. 2012; 82(3):243-7.
Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957; 54:59-68.
Romano C, Gemme G, Pongiglione R. Rare cardiac arrhythmias of the pediatric age. I. Repetitive pa-roxysmal tachycardia. Minerva Pediatr. 1963;15: 1155-64.
Cobos MA, García JC. ¿Quién fue el autor de la fór-mula de Bazett? Rev Esp Cardiol. 2008;61(8):892-8.
Lanza Tarricone G. Fórmulas para el QT corregido y consideraciones clínicas. Gac Méd Caracas. 2008; 116(3):224-34.
Viskin S, Rosovski U, Sands AJ, Chen E, Kistler PM, Kalman JM, et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physi-cians cannot recognize a long QT when they see one. Heart Rhythm. 2005;2(6):569-74.
Saul J, Berger RD, Albrecht P, Stein S, Chen MH, Co-hen RJ. Transfer function analysis of the circulation: Unique insights into cardiovascular regulation. Am J Physiol. 1991;261(4 Pt 2):H1231-45.
Llamedo M, Soria L, Arini PD, Risk MR, Laguna P. Evaluación de la corrección del intervalo QT duran-te bloqueo del sistema nervioso autónomo y cam-bios posturales. XV Congreso Argentino de Bioin-geniería. Paraná, ER. Argentina; 21-23 Septiembre 2005.
10.Ackerman MJ, Khositseth A, Tester DJ, Hejlik JB, Shen WK, Porter CB. Epinephrine-induced QT inter-val prolongation: a gene-specific paradoxical res-ponse in congenital long QT syndrome. Mayo Clin Proc. 2002;77(5):413-21.
11.Khositseth A, Hejlik J, Shen WK, Ackerman MJ. Epi-nephrine-induced T-wave notching in congenital
long QT syndrome. Heart Rhythm. 2005;2(2):141-6.
12.Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm. 2004; 1(3):276-83.
13.Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the para-doxical QT response. Circulation. 2006;113(11): 1385-92.
14.Benatar A, Decraene T. Comparison of formulae for heart rate correction of QT interval in exercise ECGs from healthy children. Heart. 2001;86(2):199-202.
15.Benatar A, Ramet J, Decraene T, Vandenplas Y. QT interval in normal infants during sleep with con-current evaluation of QT correction formulae. Med Sci Monit. 2002;8(5):CR351-6.
16.Dogan A, Tunc E, Varol E, Ozaydin M, Ozturk M. Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged heal-thy Turkish men. Ann Noninvasive Electrocardiol. 2005;10(2):134-41.
Molnar J, Weiss J, Zhang F, Rosenthal JE. Evalua-tion of five QT correction formulas using a soft-ware-assisted method of continuous QT measure-ment from 24-hour Holter recordings. Am J Cardiol. 1996;15;78(8):920-6.
18.Drezner JA, Ackerman MJ, Cannon BC, Corrado D, Heidbuchel H, Prutkin JM, et al. Abnormal elec-trocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med. 2013;47(3):153-67.
19.Spodick DH. Reduction of QT-interval imprecision and variance by measuring the JT interval. Am J Cardiol. 1992;70(1):103.
20.Das G. QT interval and repolarization time in pa-tients with intraventricular conduction delay. J Elec-trocardiol. 1990;23(1):49-52.
21.Zareba W, Moss AJ, le Cessie S, Hall WJ. T wave al-ternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994;23(7):1541-6.
22.Armoundas AA, Nanke T, Cohen RJ. T-wave al-ternans preceding torsade de pointes ventricular tachycardia. Circulation. 2000;101(21):2550.
23.Goldman DS, Zareba W, Moss AJ. Malignant T-wave alternans. Circulation. 2000;102(8):E46-7.
24.Narayan SM. T-wave alternans and the suscepti-bility to ventricular arrhythmias. J Am Coll Cardiol.
2006;47(2):269-81.
Hohnloser SH. Macroscopic T wave alternans as a harbinger of sudden death. J Cardiovasc Electro-physiol. 1999;10(4):625.
26.Grabowski M, Karpinski G, Filipiak KJ, Opolski G. Drug-induced long-QT syndrome with macroscopic T-wave alternans. Circulation. 2004;110(18):e459-60.